Ahern-Rindell A J, Prieur D J, Murnane R D, Raghavan S S, Daniel P F, McCluer R H, Walkley S U, Parish S M
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman 99164-7040.
Am J Med Genet. 1988 Sep;31(1):39-56. doi: 10.1002/ajmg.1320310108.
Histopathologic, ultrastructural and Golgi impregnation studies disclosed lesions characteristic of a neuronal lysosomal storage disease in related sheep with onset of neurologic signs at 4-6 months. Biochemical and enzymatic evaluation disclosed storage of GM1 ganglioside, asialo-GM1, and neutral long chain oligosaccharides in brain, urinary excretion of neutral long chain oligosaccharides, and deficiencies of lysosomal beta-galactosidase and alpha-neuraminidase. Retrospective and limited prospective genetic studies suggested autosomal recessive inheritance. A gene-dosage effect on beta-galactosidase levels was documented in fibroblasts from putative heterozygous sheep. Fibroblasts from affected sheep did not have increased beta-galactosidase activity after incubation with the protease inhibitor, leupeptin. In some aspects this disease is similar to GM1 gangliosidosis, but is unique in that a genetic defect in lysosomal beta-galactosidase may cause the deficiency of lysosomal alpha-neuraminidase.
组织病理学、超微结构和高尔基染色研究揭示,相关绵羊在4至6个月出现神经症状,其病变具有神经元溶酶体贮积病的特征。生化和酶学评估显示,脑内存在GM1神经节苷脂、脱唾液酸GM1和中性长链寡糖贮积,尿中排泄中性长链寡糖,且溶酶体β-半乳糖苷酶和α-神经氨酸酶缺乏。回顾性和有限的前瞻性遗传学研究提示为常染色体隐性遗传。在假定的杂合子绵羊的成纤维细胞中记录到β-半乳糖苷酶水平的基因剂量效应。患病绵羊的成纤维细胞在与蛋白酶抑制剂亮肽素孵育后,β-半乳糖苷酶活性并未增加。在某些方面,这种疾病与GM1神经节苷脂贮积症相似,但独特之处在于溶酶体β-半乳糖苷酶的基因缺陷可能导致溶酶体α-神经氨酸酶缺乏。